Retractable Technologies (NYSE:RVP) Coverage Initiated at StockNews.com

Analysts at StockNews.com started coverage on shares of Retractable Technologies (NYSE:RVP) in a note issued to investors on Thursday. The firm set a “hold” rating on the stock.

Retractable Technologies Trading Down 0.9 %

RVP opened at $0.82 on Thursday. The firm has a market cap of $24.67 million, a P/E ratio of -1.53 and a beta of 1.94. The company has a current ratio of 8.57, a quick ratio of 5.92 and a debt-to-equity ratio of 0.01. The stock has a 50-day moving average of $0.70 and a 200 day moving average of $0.81. Retractable Technologies has a 12 month low of $0.56 and a 12 month high of $1.34.

Institutional Investors Weigh In On Retractable Technologies

An institutional investor recently bought a new position in Retractable Technologies stock. PFG Investments LLC acquired a new position in Retractable Technologies, Inc. (NYSE:RVP) in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 34,600 shares of the company’s stock, valued at approximately $27,000. PFG Investments LLC owned 0.12% of Retractable Technologies at the end of the most recent reporting period. 7.58% of the stock is currently owned by institutional investors.

Retractable Technologies Company Profile

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.